|
5-Propargylamino-CTP - ATTO-740
|
|
|
|
γ-(6-Aminohexyl)-ATP - ATTO-620
|
|
|
|
γ-(6-Aminohexyl)-ATP - DY-776
|
|
|
|
DMACM-caged 8-Br-cAMP
|
|
|
|
EDA-GTP - DYQ-661
|
|
|
|
γ-[(6-Aminohexyl)-imido]-ATP
|
|
|
|
γ-(6-Aminohexyl)-ATP - DY-480XL
|
|
|
|
γ-[(6-Aminohexyl)imido]-dATP - ATTO-532
|
|
|
|
γ-(6-Aminohexyl)-ATP - OYSTER-656
|
|
|
|
N6-(6-Amino)hexyl-dATP - ATTO-680
|
|
|
|
γ-(6-Aminohexyl)-ATP
|
|
|
|
9-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-2,6-diaminopurine (FANA-DAP)
|
|
|
|
Non-hydrolyzable ATP Test Kit
|
|
|
|
N6-Benzyl-AMP
|
|
|
|
5-Propargylamino-CTP - ATTO-665
|
|
|
|
Aminoallyl-dUTP - ATTO-Rho11
|
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - ATTO-532
|
|
|
|
5-Propargylamino-dCTP - DYQ-660
|
|
|
|
5-Bromo-CTP
|
|
|
|
EDA-AppNHp (EDA-AMPPNP) - DYQ-661
|
|
|
|
5-Propargylamino-dCTP - ATTO-594
|
|
|
|
Aminoallyl-UTP - ATTO-MB2
|
|
|
|
A1 Glycan, 2-AA labelled
|
|
|
|
γ-(6-Aminohexyl)-ATP - ATTO-700
|
|
|
|
5-(3-Azidopropyl)cytidine
|
|
|
|
Aminoallyl-dUTP - ATTO-550
|
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - ATTO-MB2
|
|
|
|
EDA-GTP - MANT
|
|
|
|
EDA-ATPγS - ATTO-655
|
|
|
|
Aminoallyl-UTP - ATTO-Rho13
|
|
|
|
5-Propargylamino-dCTP - ATTO-Rho14
|
|
|
|
Aminoallyl-UTP - 6-ROX
|
|
|
|
EDA-m7GTP - 5/6-TAMRA
|
|
|
|
EDA-ATPγS - ATTO-Rho11
|
|
|
|
C11 TopFluor GM3 Ammonium salt
|
|
2260795-48-8
|
|
γ-[(8-Aminooctyl)-imido]-dCTP
|
|
|
|
5-Propargylamino-ddCTP - MANT
|
|
|
|
EDA-GTP - Texas Red
|
|
|
|
8-Morpholinyl-GTP
|
|
|
|
8-Cl-c-diAMP
|
|
|
|
EDA-AppNHp (EDA-AMPPNP) - Cy5
|
|
|
|
EDA-m7GTP - ATTO-647N
|
|
|
|
EDA-ATP - ATTO-594
|
|
|
|
β-L-Cytidine
|
|
|
|
Rp,Rp-c-diAMPSS
|
|
|
|
EDA-GTP - ATTO-740
|
|
|
|
EDA-AppNHp
|
|
|
|
γ-(6-Aminohexyl)-ATP - Cy3
|
|
|
|
AMCA-6-dUTP
|
|
|
|
S-Ethyl-CoA
|
|
|
|
dNTP Bundle incl. dUTP
|
|
|
|
6-Bnz-cAMP-AM
|
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - 6-ROX
|
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - DY-776
|
|
|
|
γ-(6-Aminohexyl)-ATP - ATTO-550
|
|
|
|
EDA-GTPγS - ATTO-594
|
|
|
|
3'-Sialyl-N-acetyllactosamine-biotin
|
|
|
|
γ-(6-Aminohexyl)-dGTP - ATTO-Rho6G
|
|
|
|
4-Chloro-5-iodo-7-(2-deoxy-3,5-bis-O-(p-toluoyl)-b-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
|
|
|
|
5'-O-DMTr-N6-ethyl-2'-deoxyadenosine
|
|
|
|
N6-(6-Amino)hexyl-dATP - 6-JOE
|
|
|
|
5-Propargylamino-dCTP - DY-485XL
|
|
|
|
EDA-GDP - ATTO-488
|
|
|
|
8-[(6-Amino)hexyl]-amino-GMP - ATTO-Rho14
|
|
|
|
3'-beta-C-Methyl-N6-isopentenyladenosine
|
|
|
|
Sp-6-AH-cAMPS
|
|
|
|
EDA-m7GTP - DY-485XL
|
|
|
|
2-(n-Propylidenehydrazino)adenosine
|
|
|
|
Blood group A type 1 tetrasaccharide-NGL
|
|
|
|
2',2''-Di-c-didAMP
|
|
79192-34-0
|
|
Larch arabinogalactan
|
|
|
|
3'-Azido-3'-deoxy-5'-O-methylthymidine
|
|
121456-54-0
|
|
2-Ethynyl-ATP (2-EATP)
|
|
|
|
γ-(6-Aminohexyl)-ATP - ATTO-Rho13
|
|
|
|
γ-[(6-Aminohexyl)imido]-dGTP - ATTO-532
|
|
|
|
Dermatan Sulfate (dp6)
|
|
|
|
(±)-trans-4-(2-Nitrophenyl)pyrrolidine-3-carboxylic acid hydrochloride
|
|
|
|
EDA-m7GDP - Cy5
|
|
|
|
EDA-m7GDP - ATTO-565
|
|
|
|
AP2Ribavirin
|
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - ATTO-565
|
|
|
|
N1-Methyl-2'-O-(2-methoxyethyl)adenosine
|
|
|
|
EDA-m7GTP - ATTO-680
|
|
|
|
5-Propargylamino-ddCTP - OYSTER-656
|
|
|
|
8-[(6-Amino)hexyl]-amino-GMP - ATTO-633
|
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - ATTO-633
|
|
|
|
7-Deaza-7-iodo-dGTP
|
|
|
|
EDA-m7GDP - ATTO-MB2
|
|
|
|
EDA-m7GDP - ATTO-594
|
|
|
|
EDA-m7GDP - ATTO-590
|
|
|
|
Sp-2-AHA-cAMPS-Agarose
|
|
|
|
7-Deaza-dGMP
|
|
|
|
5-Propargylamino-dCTP - 6-JOE
|
|
|
|
N1-Methyl-2'-O-(2-methoxyethyl)inosine
|
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - ATTO-740
|
|
|
|
EDA-m7GDP - MANT
|
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - ATTO-594
|
|
|
|
N1-Methyl-2'-deoxy-2'-fluoroarabinoadenosine
|
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - MANT
|
|
|
|
Cytidine (N-PAC)
|
|
|